跳至主要内容
临床试验/NCT00682747
NCT00682747终止2 期

Randomized Phase II Trial of Hyperbaric Oxygen for the Treatment of Radiation-induced Xerostomia

Thomas Kuhnt2 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2008年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
终止
发起方
Thomas Kuhnt
入组人数
13
试验地点
2
主要终点
change of overall salivation (millilitre per minute over 5 minutes measured at rest and after provocation) in percentages

研究概览

简要总结

The purpose of this study is to determine whether hyperbaric oxygen is effective in the treatment of a dry mouth that occured after radiotherapy for head and neck tumours.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • complaints of xerostomia (visual analogue scale)
  • at least 6 months after radiotherapy of the head and neck region including all salivary glands with at least 50 Gy
  • objective hyposalivation / xerostomia (at rest < 0,25 ml saliva per minute, stimulated < 0,1 ml saliva per minute)
  • patient must have given written informed consent

排除标准

  • prior radiotherapy was an intensity modulated radiotherapy
  • prior hyperbaric oxygen therapy after radiotherapy
  • conditions which might be an additional risk for the treatment with hyperbaric oxygen such as spontaneous pneumothorax within the last two years, surgery of the eardrum or the middle ear, acute infection of the upper airways, not adequately treated epilepsy, concurrent radio- or chemotherapy, hereditary spherocytosis, psychosis, lung emphysema, asthma, severe COPD, prior surgery of the thorax, pace maker
  • myocardial infarction within the last 6 months
  • drug therapy which might induce xerostomia
  • known intolerance or hypersensitivity to Wrigley's Freident®
  • pregnancy or breast-feeding women (for women aged less than 60 years a pregnancy test is mandatory)
  • women of childbearing potential with unclear contraception. The following contraceptive methods are recommended: combined oral contraceptives or progesterone-only pill, hormone-dispensing or copper intra-uterine system, hormone patches, long-acting injections, vaginal ring
  • treatment with other investigational drugs or participation in another clinical trial within 30 days prior to enrollment
  • refusal of cooperation or consent

研究组 & 干预措施

HBO

Experimental

40 treatments with hyperbaric oxygen once per day, five days per week, 2.4 ATA, 100 % oxygen (10-15 minutes compression with air, 90 min of oxygen breathing - two 10 minutes break for breathing air after each 30 minutes of oxygen, 10 minutes decompression with oxygen)

干预措施: Hyperbaric oxygen (Drug)

结局指标

主要结局

change of overall salivation (millilitre per minute over 5 minutes measured at rest and after provocation) in percentages

时间窗: baseline compared with measures on day 28, 56 and 146

次要结局

  • Improvement of symptoms/discomfort due to xerestomia assessed by the patient on a visual analogue scale(baseline compared with measures on day 28, 56 and 146)
  • Number of Adverse Events in all patients as a Measure of Safety and Tolerability(baseline until 4 weeks after end of study treatment)
  • Xerostomia scores assessed by investigator according to Eisbruch et.al.(baseline compared with measures on day 28, 56 and 146)
  • quality of life measures (EORTC QLQ-H&N 35)(baseline compared with measures on day 28, 56 and 146)

研究者

发起方
Thomas Kuhnt
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Thomas Kuhnt

Dr. med.

Martin-Luther-Universität Halle-Wittenberg

研究点 (2)

Loading locations...

相似试验

Hyperbaric Oxygen for the Treatment of a Dry Mouth... | 临床试验